Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

N4 Pharma Plc (N4P)

Price 0.775p on 26-04-2024 at 16:30:02
Change -0.05p -6.06%
Buy 0.80p
Sell 0.75p
Buy / Sell N4P Shares
Last Trade: Buy 500.00 at 0.80p
Day's Volume: 611,345
Last Close: 0.775p
Open: 0.825p
ISIN: GB00BYW8QM32
Day's Range 0.775p - 0.825p
52wk Range: 0.625p - 2.10p
Market Capitalisation: £2m
VWAP: 0.767177p
Shares in Issue: 269m

Recent Trades History N4 Pharma Plc (N4P)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 500 0.80p Ordinary
15:18:04 - 26-Apr-24
Sell* 90,000 0.768p Ordinary
14:32:39 - 26-Apr-24
Sell* 2,476 0.765p Ordinary
14:22:33 - 26-Apr-24
Sell* 200 0.765p Ordinary
14:03:49 - 26-Apr-24
Sell* 1,550 0.75p SI Trade
13:48:09 - 26-Apr-24
Buy* 117 0.85p SI Trade
12:40:46 - 26-Apr-24
Buy* 5,000 0.85p SI Trade
12:40:46 - 26-Apr-24
Buy* 10,000 0.825p Ordinary
12:09:44 - 26-Apr-24
Sell* 1,000 0.765p Ordinary
09:40:40 - 26-Apr-24
Sell* 250,000 0.765p Ordinary
09:36:51 - 26-Apr-24

Share Price History for N4 Pharma Plc

Time period:
to
Date Open High Low Close Volume

Share News for N4 Pharma Plc

N4 Pharma strikes partnership deal for intracellular delivery

25th Apr 2024 11:56

(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc. Read More

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

23rd Apr 2024 13:32

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to no revenue a year ago. Pretax loss widens to GBP1.4 million from GBP1.2 million. Looks ahead to the rest of 2024 with "great optimism." Read More

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

18th Apr 2024 12:14

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial. Read More

IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research

15th Feb 2024 12:06

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - Reports an "encouraging" update from its Nuvec delivery system for cancer treatments, gene therapy and vaccines. It has completed in-vitro experiments combining epidermal growth factor receptor and polo like kinase 1 molecules onto a Nuvec nanoparticle, before testing it on lung cancer cells. "The work clearly shows that there is a strong beneficial effect at 48 hours on cellular inhibition compared to single dose siRNA, by combining both EGFR and PLK1 onto the same particle," N4 says. Read More

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

15th Feb 2024 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

FTSE 100 Latest
Value8,139.83
Change60.97

Login to your account

Forgot Password?

Not Registered